Edesa Biotech Inc
NASDAQ:EDSA
Edesa Biotech Inc
NASDAQ:EDSA
Price:
5.22
USD
-11.53%
Market Closed
Market Cap:
$43.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Edesa Biotech Inc
NASDAQ:EDSA
|
CA |
|
PT ITSEC Asia Tbk
IDX:CYBR
|
ID |
|
TechnologyOne Ltd
ASX:TNE
|
AU |
|
Eguana Technologies Inc
XTSX:EGT
|
CA |
|
Pinetree Capital Ltd
TSX:PNP
|
CA |
|
N
|
North American Construction Group Ltd
SWB:N5Z
|
CA |
|
Thinking Electronic Industrial Co Ltd
TWSE:2428
|
TW |
|
J
|
Jiangsu Yueda Investment Co Ltd
SSE:600805
|
CN |
|
Ethos Gold Corp
XTSX:ECC
|
CA |
|
Marine Electricals (India) Ltd
NSE:MARINE
|
IN |
|
Evolent Health Inc
NYSE:EVH
|
US |
|
M
|
Magnificent Hotel Investments Ltd
HKEX:201
|
HK |
|
Bread Financial Holdings Inc
NYSE:BFH
|
US |
Multiples-Based Value
The Multiples-Based Value of one
EDSA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.22 USD,
Edesa Biotech Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EDSA Multiples-Based Value
LOCKED
Multiples Across Competitors
EDSA Competitors Multiples
Edesa Biotech Inc Competitors
Edesa Biotech Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Edesa Biotech Inc
NASDAQ:EDSA
|
43.5m USD | 0 | -5.6 | -3.8 | -3.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.5 | 42.8 | 43.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.2B AUD | 3 | 32.6 | 11 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
